GENE ONLINE|News &
Opinion
Blog

Daniel Ojeda

WRITTEN BY Daniel Ojeda

Scientists Successfully Use Gold-Nanoparticles to Deliver Novel Therapy for Brain Tumor
2021-03-16
With $74 Million in Fresh Capital, Belgian Startup Aims to Advance its Regenerative Pathway Modulators
2021-03-11
Gilead Reports FDA-Approved HIV Therapy Demonstrates Long-Term Efficacy
2021-03-11
Gilead’s Breakthrough CAR-T Becomes First to Get FDA Approval for Indolent Follicular Lymphoma
2021-03-07
Amgen Signs $1.9 Billion Worth Cancer Deal, Nurtures Growth Aspirations in Asia with New Oncology Assets
2021-03-07
Phase 2 Trial Setback of Investigational IBS Drug Prompts Arena to Ponder Strategic Alternatives
2021-03-04
FDA Rejects Athenex’s Breast Cancer Treatment, Recommends Another Clinical Trial
2021-03-03
Third COVID Vaccine on the Cards as FDA Panel Unanimously Recommends J&J’s Single Shot Candidate
2021-02-26
Astellas’ Non-Hormonal Drug for Hot Flashes Shows Promise in Two Phase 3 Trials
2021-02-24
BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs
2021-02-21
Pfizer’s Panzyga Receives FDA Approval for Rare Neurological Disease
2021-02-17
Texas Biopharma Inks $1.3 Billion Worth BMS Deal to Develop Engineered Toxin Bodies
2021-02-14
FDA Okay of Regeneron’s PD-1 Inhibitor Marks Entry of First Immunotherapy for Advanced Basal Cell Carcinoma
2021-02-12
South Africa Defers AstraZeneca Vaccinations as Vaccine Only Provides Minimal Protection against COVID-19 Variant
2021-02-09
Vor BioPharma Surpasses $1 Billion Valuation After IPO
2021-02-07
1 … 4 5 6 7 8 9
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top